The Role of the P2X7 Receptor in Cancer Development and Progression
Keywords:
N\AAbstract
N\A
Downloads
Metrics
References
Lara R, Adinolfi E, Harwood CA, Philpott M, Barden JA, Di Virgilio F, McNulty S. P2X7 in Cancer: From Molecular Mechanisms to Therapeutics. Front Pharmacol. 2020 Jun 4;11:793. doi: 10.3389/fphar.2020.00793. PMID: 32581786; PMCID: PMC7287489.
Sainz RM, Rodriguez-Quintero JH, Maldifassi MC, Stiles BM, Wennerberg E. Tumour immune escape via P2X7 receptor signalling. Front Immunol. 2023 Oct 30;14:1287310. doi: 10.3389/fimmu.2023.1287310. PMID: 38022596; PMCID: PMC10643160.
Zhang GP, Liao JX, Liu YY, Zhu FQ, Huang HJ, Zhang WJ. Ion channel P2X7 receptor in the progression of cancer. Front Oncol. 2024 Jan 11;13:1297775. doi: 10.3389/fonc.2023.1297775. PMID: 38273855; PMCID: PMC10808724.
De Marchi E, Pegoraro A, Adinolfi E. P2X7 Receptor in Hematological Malignancies. Front Cell Dev Biol. 2021 Mar 5;9:645605. doi: 10.3389/fcell.2021.645605. PMID: 33763425; PMCID: PMC7982859.
cancerindex.org P2RX7 | Cancer Genetics Web
Rabelo ILA, Arnaud-Sampaio VF, Adinolfi E, Ulrich H, Lameu C. Cancer Metabostemness and Metabolic Reprogramming via P2X7 Receptor. Cells. 2021 Jul 14;10(7):1782. doi: 10.3390/cells10071782. PMID: 34359950; PMCID: PMC8305434.
Ribeiro DE, Roncalho AL, Glaser T, Ulrich H, Wegener G, Joca S. P2X7 Receptor Signaling in Stress and Depression. Int J Mol Sci. 2019 Jun 6;20(11):2778. doi: 10.3390/ijms20112778. PMID: 31174279; PMCID: PMC6600521.
spandidos-publications.com
www.spandidos-publications.com
Zheng H, Liu Q, Zhou S, Luo H, Zhang W. Role and therapeutic targets of P2X7 receptors in neurodegenerative diseases. Front Immunol. 2024 Feb 2;15:1345625. doi: 10.3389/fimmu.2024.1345625. PMID: 38370420; PMCID: PMC10869479.
De Marchi E, Pegoraro A, Adinolfi E. P2X7 Receptor in Hematological Malignancies. Front Cell Dev Biol. 2021 Mar 5;9:645605. doi: 10.3389/fcell.2021.645605. PMID: 33763425; PMCID: PMC7982859.
Рецептор P2X7 в биологии и заболеваниях кожи Автор Николас Дж. Джерати, Дебби Уотсон, Сэм Р. Адикари, Рональд Слайтер
Автор-корреспондент Рональд Слейтер, доктор философии, доцент, факультет биологических наук, Университет Вуллонгонга, Нортфилдс Авеню, Вуллонгонг NSW 2522, Австралия.rsluyter@uow.edu.au
Lara R, Adinolfi E, Harwood CA, Philpott M, Barden JA, Di Virgilio F, McNulty S. P2X7 in Cancer: From Molecular Mechanisms to Therapeutics. Front Pharmacol. 2020 Jun 4;11:793. doi: 10.3389/fphar.2020.00793. PMID: 32581786; PMCID: PMC7287489.
Salvestrini V, Orecchioni S, Talarico G, Reggiani F, Mazzetti C, Bertolini F, Orioli E, Adinolfi E, Di Virgilio F, Pezzi A, Cavo M, Lemoli RM, Curti A. Extracellular ATP induces apoptosis through P2X7R activation in acute myeloid leukemia cells but not in normal hematopoietic stem cells. Oncotarget. 2017 Jan 24;8(4):5895-5908. doi: 10.18632/oncotarget.13927. PMID: 27980223; PMCID: PMC5351599.
Kopp R, Krautloher A, Ramírez-Fernández A, Nicke A. P2X7 Interactions and Signaling - Making Head or Tail of It. Front Mol Neurosci. 2019 Aug 7;12:183. doi: 10.3389/fnmol.2019.00183. PMID: 31440138; PMCID: PMC6693442.
Zhang X, Meng L, He B, Chen J, Liu P, Zhao J, Zhang Y, Li M, An D. The role of P2X7 receptor in ATP-mediated human leukemia cell death: calcium influx-independent. Acta Biochim Biophys Sin (Shanghai). 2009 May;41(5):362-9. doi: 10.1093/abbs/gmp016. PMID: 19430700.
Rotondo JC, Mazziotta C, Lanzillotti C, Stefani C, Badiale G, Campione G, Martini F, Tognon M. The Role of Purinergic P2X7 Receptor in Inflammation and Cancer: Novel Molecular Insights and Clinical Applications. Cancers (Basel). 2022 Feb 22;14(5):1116. doi: 10.3390/cancers14051116. PMID: 35267424; PMCID: PMC8909580.
Feng W, Yang X, Wang L, Wang R, Yang F, Wang H, Liu X, Ren Q, Zhang Y, Zhu X, Zheng G. P2X7 promotes the progression of MLL-AF9 induced acute myeloid leukemia by upregulation of Pbx3. Haematologica. 2021 May 1;106(5):1278-1289. doi: 10.3324/haematol.2019.243360. PMID: 32165482; PMCID: PMC8094107.
Furlan-Freguia C, Marchese P, Gruber A, Ruggeri ZM, Ruf W. P2X7 receptor signaling contributes to tissue factor-dependent thrombosis in mice. J Clin Invest. 2011 Jul;121(7):2932-44. doi: 10.1172/JCI46129. Epub 2011 Jun 13. PMID: 21670495; PMCID: PMC3127437.
Changizi Z, Moslehi A, Rohani AH, Eidi A. Chlorogenic acid induces 4T1 breast cancer tumor's apoptosis via p53, Bax, Bcl-2, and caspase-3 signaling pathways in BALB/c mice. J Biochem Mol Toxicol. 2021 Feb;35(2):e22642. doi: 10.1002/jbt.22642. Epub 2020 Oct 15. PMID: 33058431.
Salahuddin MM, Omran GA, Helmy MW, Houssen ME. Effect of Regorafenib on P2X7 Receptor Expression and Different Oncogenic Signaling Pathways in a Human Breast Cancer Cell Line: A Potential of New Insight of the Antitumor Effects of Regorafenib. Curr Issues Mol Biol. 2021 Dec 9;43(3):2199-2209. doi: 10.3390/cimb43030154. PMID: 34940128; PMCID: PMC8929109.
Feng W, Yang X, Wang L, Wang R, Yang F, Wang H, Liu X, Ren Q, Zhang Y, Zhu X, Zheng G. P2X7 promotes the progression of MLL-AF9 induced acute myeloid leukemia by upregulation of Pbx3. Haematologica. 2021 May 1;106(5):1278-1289. doi: 10.3324/haematol.2019.243360. PMID: 32165482; PMCID: PMC8094107.
Pegoraro A, Adinolfi E. The ATP/P2X7 axis is a crucial regulator of leukemic initiating cells proliferation and homing and an emerging therapeutic target in acute myeloid leukemia. Purinergic Signal. 2021 Sep;17(3):319-321. doi: 10.1007/s11302-021-09789-4. Epub 2021 Jun 1. PMID: 34075525; PMCID: PMC8410923.
Pegoraro A, De Marchi E, Ferracin M, Orioli E, Zanoni M, Bassi C, Tesei A, Capece M, Dika E, Negrini M, Di Virgilio F, Adinolfi E. P2X7 promotes metastatic spreading and triggers release of miRNA-containing exosomes and microvesicles from melanoma cells. Cell Death Dis. 2021 Nov 16;12(12):1088. doi: 10.1038/s41419-021-04378-0. PMID: 34789738; PMCID: PMC8599616.
De Marchi E, Pegoraro A, Turiello R, Di Virgilio F, Morello S, Adinolfi E. A2A Receptor Contributes to Tumor Progression in P2X7 Null Mice. Front Cell Dev Biol. 2022 May 18;10:876510. doi: 10.3389/fcell.2022.876510. PMID: 35663396; PMCID: PMC9159855.
Adinolfi E, De Marchi E, Grignolo M, Szymczak B, Pegoraro A. The P2X7 Receptor in Oncogenesis and Metastatic Dissemination: New Insights on Vesicular Release and Adenosinergic Crosstalk. Int J Mol Sci. 2023 Sep 9;24(18):13906. doi: 10.3390/ijms241813906. PMID: 37762206; PMCID: PMC10531279.pmc.ncbi.nlm.nih.gov
Tanamachi K, Nishino K, Mori N, Suzuki T, Tanuma SI, Abe R, Tsukimoto M. Radiosensitizing Effect of P2X7 Receptor Antagonist on Melanoma in Vitro and in Vivo. Biol Pharm Bull. 2017 Jun 1;40(6):878-887. doi: 10.1248/bpb.b17-00083. Epub 2017 Mar 24. PMID: 28344198.
Adinolfi E, Capece M, Franceschini A, Falzoni S, Giuliani AL, Rotondo A, Sarti AC, Bonora M, Syberg S, Corigliano D, Pinton P, Jorgensen NR, Abelli L, Emionite L, Raffaghello L, Pistoia V, Di Virgilio F. Accelerated tumor progression in mice lacking the ATP receptor P2X7. Cancer Res. 2015 Feb 15;75(4):635-44. doi: 10.1158/0008-5472.CAN-14-1259. Epub 2014 Dec 26. PMID: 25542861.
Santana, P.T.; de Lima, I.S.; Silva e Souza, K.C.d.; Barbosa, P.H.S.; de Souza, H.S.P. Persistent Activation of the P2X7 Receptor Underlies Chronic Inflammation and Carcinogenic Changes in the Intestine. Int. J. Mol. Sci. 2024, 25, 10874. https://doi.org/10.3390/ijms252010874
Calik I, Calik M, Turken G, Ozercan IH. A promising independent prognostic biomarker in colorectal cancer: P2X7 receptor. Int J Clin Exp Pathol. 2020 Feb 1;13(2):107-121. PMID: 32211091; PMCID: PMC7061807.
Bernardazzi C, Castelo-Branco MTL, Pêgo B, Ribeiro BE, Rosas SLB, Santana PT, Machado JC, Leal C, Thompson F, Coutinho-Silva R, de Souza HSP. The P2X7 Receptor Promotes Colorectal Inflammation and Tumorigenesis by Modulating Gut Microbiota and the Inflammasome. Int J Mol Sci. 2022 Apr 21;23(9):4616. doi:10.3390/ijms23094616. PMID: 35563010; PMCID: PMC9099551.
Cao Y, Du Y, Song W, Yu Q, Wang X, Zhao R, Peng X. Role and Therapeutic Potential of P2X7 Receptor in Lung Cancer Progression. Curr Med Chem. 2024 Sep 9. doi: 10.2174/0109298673331527240829080249. Epub ahead of print. PMID: 39252620.
Bernardazzi C, Castelo-Branco MTL, Pêgo B, Ribeiro BE, Rosas SLB, Santana PT, Machado JC, Leal C, Thompson F, Coutinho-Silva R, de Souza HSP. The P2X7 Receptor Promotes Colorectal Inflammation and Tumorigenesis by Modulating Gut Microbiota and the Inflammasome. Int J Mol Sci. 2022 Apr 21;23(9):4616. doi: 10.3390/ijms23094616. PMID: 35563010; PMCID: PMC9099551.
Li Q, Zhu X, Song W, Peng X, Zhao R. The P2X7 purinergic receptor: a potential therapeutic target for lung cancer. J Cancer Res Clin Oncol. 2020 Nov;146(11):2731-2741. doi: 10.1007/s00432-020-03379-4. Epub 2020 Sep 5. PMID: 32892231.
Zhang GP, Liao JX, Liu YY, Zhu FQ, Huang HJ, Zhang WJ. Ion channel P2X7 receptor in the progression of cancer. Front Oncol. 2024 Jan 11;13:1297775. doi: 10.3389/fonc.2023.1297775. PMID: 38273855; PMCID: PMC10808724.
Bernardazzi C, Castelo-Branco MTL, Pêgo B, Ribeiro BE, Rosas SLB, Santana PT, Machado JC, Leal C, Thompson F, Coutinho-Silva R, de Souza HSP. The P2X7 Receptor Promotes Colorectal Inflammation and Tumorigenesis by Modulating Gut Microbiota and the Inflammasome. Int J Mol Sci. 2022 Apr 21;23(9):4616. doi: 10.3390/ijms23094616. PMID: 35563010; PMCID: PMC9099551.
Li Q, Zhu X, Song W, Peng X, Zhao R. The P2X7 purinergic receptor: a potential therapeutic target for lung cancer. J Cancer Res Clin Oncol. 2020 Nov;146(11):2731-2741. doi: 10.1007/s00432-020-03379-4. Epub 2020 Sep 5. PMID: 32892231.
Nuñez-Ríos JD, Reyna-Jeldes M, Mata-Martínez E, Campos-Contreras ADR, Lazcano-Sánchez I, González-Gallardo A, Díaz-Muñoz M, Coddou C, Vázquez-Cuevas FG. Extracellular ATP/P2X7 receptor, a regulatory axis of migration in ovarian carcinoma-derived cells. PLoS One. 2024 Jun 13;19(6):e0304062. doi: 10.1371/journal.pone.0304062. PMID: 38870128; PMCID: PMC11175443.
Grassi F, De Ponte Conti B. The P2X7 Receptor in Tumor Immunity. Front Cell Dev Biol. 2021 Jun 22;9:694831. doi: 10.3389/fcell.2021.694831. PMID: 34239877; PMCID: PMC8258391.
Matyśniak D, Chumak V, Nowak N, Kukla A, Lehka L, Oslislok M, Pomorski P. P2X7 receptor: the regulator of glioma tumor development and survival. Purinergic Signal. 2022 Mar;18(1):135-154. doi: 10.1007/s11302-021-09834-2. Epub 2021 Dec 29. PMID: 34964926; PMCID: PMC8850512.
Nuñez-Ríos JD, Reyna-Jeldes M, Mata-Martínez E, Campos-Contreras ADR, Lazcano-Sánchez I, González-Gallardo A, Díaz-Muñoz M, Coddou C, Vázquez-Cuevas FG. Extracellular ATP/P2X7 receptor, a regulatory axis of migration in ovarian carcinoma-derived cells. PLoS One. 2024 Jun 13;19(6):e0304062. doi: 10.1371/journal.pone.0304062. PMID: 38870128; PMCID: PMC11175443.
Matyśniak D, Chumak V, Nowak N, Kukla A, Lehka L, Oslislok M, Pomorski P. P2X7 receptor: the regulator of glioma tumor development and survival. Purinergic Signal. 2022 Mar;18(1):135-154. doi: 10.1007/s11302-021-09834-2. Epub 2021 Dec 29. PMID: 34964926; PMCID: PMC8850512.
Giannuzzo A, Saccomano M, Napp J, Ellegaard M, Alves F, Novak I. Targeting of the P2X7 receptor in pancreatic cancer and stellate cells. Int J Cancer. 2016 Dec 1;139(11):2540-52. doi: 10.1002/ijc.30380. Epub 2016 Aug 29. PMID: 27513892; PMCID: PMC5095874.
Xia J, Yu X, Tang L, Li G, He T. P2X7 receptor stimulates breast cancer cell invasion and migration via the AKT pathway. Oncol Rep. 2015 Jul;34(1):103-10. doi: 10.3892/or.2015.3979. Epub 2015 May 13. PMID: 25976617.
Di Giuseppe, F., Ricci-Vitiani, L., Pallini, R., Di Pietro, R., Di Iorio, P., Ascani, G., Ciccarelli, R., & Angelucci, S. (2024). Changes Induced by P2X7 Receptor Stimulation of Human Glioblastoma Stem Cells in the Proteome of Extracellular Vesicles Isolated from Their Secretome. Cells, 13(7), 571. https://doi.org/10.3390/cells13070571
Liyen Katrina Kan, Kate J. Drummond. Sinali Seneviratne, David Williams. September 2020.Purinergic Signalling. P2X7 receptor antagonism inhibits tumour growth in human high-grade gliomas. DOI:10.1007/s11302-020-09705-2
Magni L, Bouazzi R, Heredero Olmedilla H, Petersen PSS, Tozzi M, Novak I. The P2X7 Receptor Stimulates IL-6 Release from Pancreatic Stellate Cells and Tocilizumab Prevents Activation of STAT3 in Pancreatic Cancer Cells. Cells. 2021 Jul 29;10(8):1928. doi: 10.3390/cells10081928. PMID: 34440697; PMCID: PMC8391419.
Bergamin LS, Capece M, Salaro E, Sarti AC, Falzoni S, Pereira MSL, De Bastiani MA, Scholl JN, Battastini AMO, Di Virgilio F. Role of the P2X7 receptor in in vitro and in vivo glioma tumor growth. Oncotarget. 2019 Aug 6;10(47):4840-4856. doi: 10.18632/oncotarget.27106. PMID: 31448051; PMCID: PMC6690673.
Vázquez-Cuevas FG, Martínez-Ramírez AS, Robles-Martínez L, Garay E, García-Carrancá A, Pérez-Montiel D, Castañeda-García C, Arellano RO. Paracrine stimulation of P2X7 receptor by ATP activates a proliferative pathway in ovarian carcinoma cells. J Cell Biochem. 2014 Nov;115(11):1955-66. doi: 10.1002/jcb.24867. PMID: 24913779.
Andrejew R, Oliveira-Giacomelli Á, Ribeiro DE, Glaser T, Arnaud-Sampaio VF, Lameu C, Ulrich H. The P2X7 Receptor: Central Hub of Brain Diseases. Front Mol Neurosci. 2020 Jul 31;13:124. doi: 10.3389/fnmol.2020.00124. PMID: 32848594; PMCID: PMC7413029.
Bergamin LS, Capece M, Salaro E, Sarti AC, Falzoni S, Pereira MSL, De Bastiani MA, Scholl JN, Battastini AMO, Di Virgilio F. Role of the P2X7 receptor in in vitro and in vivo glioma tumor growth. Oncotarget. 2019 Aug 6;10(47):4840-4856. doi: 10.18632/oncotarget.27106. PMID: 31448051; PMCID: PMC6690673.
Haanes KA, Schwab A, Novak I. The P2X7 receptor supports both life and death in fibrogenic pancreatic stellate cells. PLoS One. 2012;7(12):e51164. doi: 10.1371/journal.pone.0051164. Epub 2012 Dec 17. PMID: 23284663; PMCID: PMC3524122.
Choi JH, Ji YG, Ko JJ, Cho HJ, Lee DH. Activating P2X7 Receptors Increases Proliferation of Human Pancreatic Cancer Cells via ERK1/2 and JNK. Pancreas. 2018 May/Jun;47(5):643-651. doi: 10.1097/MPA.0000000000001055. PMID: 29683976.
Mohammed A, Janakiram NB, Madka V, Pathuri G, Li Q, Ritchie R, Biddick L, Kutche H, Zhang Y, Singh A, Gali H, Lightfoot S, Steele VE, Suen CS, Rao CV. Lack of chemopreventive effects of P2X7R inhibitors against pancreatic cancer. Oncotarget. 2017 Oct 26;8(58):97822-97834. doi: 10.18632/oncotarget.22085. PMID: 29228654; PMCID: PMC5716694.
Adinolfi E, De Marchi E, Grignolo M, Szymczak B, Pegoraro A. The P2X7 Receptor in Oncogenesis and Metastatic Dissemination: New Insights on Vesicular Release and Adenosinergic Crosstalk. Int J Mol Sci. 2023 Sep 9;24(18):13906. doi: 10.3390/ijms241813906. PMID: 37762206; PMCID: PMC10531279.
Adinolfi E, Raffaghello L, Giuliani AL, Cavazzini L, Capece M, Chiozzi P, Bianchi G, Kroemer G, Pistoia V, Di Virgilio F. Expression of P2X7 receptor increases in vivo tumor growth. Cancer Res. 2012 Jun 15;72(12):2957-69. doi: 10.1158/0008-5472.CAN-11-1947. Epub 2012 Apr 13. PMID: 22505653.
Qiao C, Tang Y, Li Q, Zhu X, Peng X, Zhao R. ATP-gated P2X7 receptor as a potential target for prostate cancer. Hum Cell. 2022 Sep;35(5):1346-1354. doi: 10.1007/s13577-022-00729-x. Epub 2022 Jun 3. PMID: 35657562.
Solini A, Simeon V, Derosa L, Orlandi P, Rossi C, Fontana A, Galli L, Di Desidero T, Fioravanti A, Lucchesi S, Coltelli L, Ginocchi L, Allegrini G, Danesi R, Falcone A, Bocci G. Genetic interaction of P2X7 receptor and VEGFR-2 polymorphisms identifies a favorable prognostic profile in prostate cancer patients. Oncotarget. 2015 Oct 6;6(30):28743-54. doi: 10.18632/oncotarget.4926. PMID: 26337470; PMCID: PMC4745689.
Bipin Singih, Vishal Kajla, Neha Bala, Raveena Jassal.INVESTIGATING THERAPEUTIC POTENTIAL: P2X7 RECEPTOR ANTAGONISTS IN COMBATING CHRONIC COMPLICATIONS *Corresponding Author. September 2024. World Journal of Pharmaceutical Research Vol 13(Issue 18, 2024.):414-435. DOI:10.20959/wjpr202418-33937
Soni S, Lukhey MS, Thawkar BS, Chintamaneni M, Kaur G, Joshi H, Ramniwas S, Tuli HS. A current review on P2X7 receptor antagonist patents in the treatment of neuroinflammatory disorders: a patent review on antagonists. Naunyn Schmiedebergs Arch Pharmacol. 2024 Jul;397(7):4643-4656. doi: 10.1007/s00210-024-02994-z. Epub 2024 Feb 13. PMID: 38349395.
Shokoples BG, Paradis P, Schiffrin EL. P2X7 Receptors: An Untapped Target for the Management of Cardiovascular Disease. Arterioscler Thromb Vasc Biol. 2021 Jan;41(1):186-199. doi: 10.1161/ATVBAHA.120.315116. Epub 2020 Oct 1. PMID: 32998520; PMCID: PMC7752223.
Franceschini A, Adinolfi E. P2X receptors: New players in cancer pain. World J Biol Chem. 2014 Nov 26;5(4):429-36. doi: 10.4331/wjbc.v5.i4.429. PMID: 25426266; PMCID: PMC4243147.
Drill M, Jones NC, Hunn M, O'Brien TJ, Monif M. Antagonism of the ATP-gated P2X7 receptor: a potential therapeutic strategy for cancer. Purinergic Signal. 2021 Jun;17(2):215-227. doi:10.1007/s11302021-09776-9. Epub 2021 Mar 17. PMID: 33728582; PMCID: PMC8155177.
Alba Sarti, Francesco Di Virgilio Valentina Vultaggio Poma. P2X7: a receptor with a split personality that raises new hopes for anti-cancer therapy. April 2021. Purinergic Signalling 17(1). DOI:10.1007/s11302-021-09783-w
Burnstock G, Knight GE. The potential of P2X7 receptors as a therapeutic target, including inflammation and tumour progression. Purinergic Signal. 2018 Mar;14(1):1-18. doi: 10.1007/s11302-017-9593-0. Epub 2017 Nov 21. PMID: 29164451; PMCID: PMC5842154.
Drill M, Jones NC, Hunn M, O'Brien TJ, Monif M. Antagonism of the ATP-gated P2X7 receptor: a potential therapeutic strategy for cancer. Purinergic Signal. 2021 Jun;17(2):215-227. doi: 10.1007/s11302-021-09776-9. Epub 2021 Mar 17. PMID: 33728582; PMCID: PMC8155177.
Di Virgilio F, Vultaggio-Poma V, Falzoni S, Giuliani AL. The Coming of Age of the P2X7 Receptor in Diagnostic Medicine. Int J Mol Sci. 2023 May 30;24(11):9465. doi: 10.3390/ijms24119465. PMID: 37298415; PMCID: PMC10253666.
alzdiscovery.org P2X7R Inhibitors - Alzheimer's Drug Discovery Foundation
Xioming Liu, Yingyan Kuang, Beibei Zhao, Liwen Li, Xiaoxiong Wu, Jiao Lan, Liting Huang, Xiangqiong Ma.Unlocking the therapeutic potential of P2X7 receptor: a comprehensive review of its role in neurodegenerative disorders. Front. Pharmacol., 30 July 2024 Sec. Pharmacology of Ion Channels and Channelopathies Volume 15 - 2024 | https://doi.org/10.3389/fphar.2024.1450704
Lara R, Adinolfi E, Harwood CA, Philpott M, Barden JA, Di Virgilio F, McNulty S. P2X7 in Cancer: From Molecular Mechanisms to Therapeutics. Front Pharmacol. 2020 Jun 4;11:793. doi: 10.3389/fphar.2020.00793. PMID: 32581786; PMCID: PMC7287489.
Bergamin LS, Capece M, Salaro E, Sarti AC, Falzoni S, Pereira MSL, De Bastiani MA, Scholl JN, Battastini AMO, Di Virgilio F. Role of the P2X7 receptor in in vitro and in vivo glioma tumor growth. Oncotarget. 2019 Aug 6;10(47):4840-4856. doi: 10.18632/oncotarget.27106. PMID: 31448051; PMCID: PMC6690673.
.
Downloads
Published
How to Cite
Issue
Section
License
This work is licensed under a Creative Commons Attribution 4.0 International License.
You are free to:
- Share — copy and redistribute the material in any medium or format
- Adapt — remix, transform, and build upon the material for any purpose, even commercially.
Terms:
- Attribution — You must give appropriate credit, provide a link to the license, and indicate if changes were made. You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.
- No additional restrictions — You may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.
